… tyrosine kinases (PTKs). PTKs are positioned in key crossroads within the cellular communication
network and function as master switches. Their regulated signaling is pivotal to normal …

… Protein tyrosine kinases (PTKs) play a key role in normal cell … tyrosine phosphorylation
inhibitors (tyrphostins) as potential … , as well as at nonreceptor, tyrosine kinases. Some of these …

… tyrosine kinases as potential drug targets in a number of diseases and deficiencies in the
following way: “…there is a long list of tyrosine kinases … therapeutic potentials of BTK inhibitors. …

… Resistance to the therapeutic potential of TKIs can be acquired or intrinsic. Alternative
therapies include other small molecule drugs and immunotherapy based on immune checkpoint …

Introduction: Tyrosine kinase 2 (Tyk2) is a Janus kinase family member that is crucial for
signaling transduction in response to a wide variety of cytokines, including type I IFNs, IL-6, IL-10…

… Many tyrosine kinase inhibitors are available as orally administered regimes like as … for
therapeutic. In the present review, we particularly focus on orally active tyrosine kinase inhibitors …

… BY-kinases (for Bacterial tyrosine-kinases) [28]. In this review, we will focus on functional
and structural aspects of BY-kinases and their potential utilization as therapeutic targets. …

… together with protein tyrosine kinases, regulate tyrosine phosphorylation inside … tyrosine
phosphorylation offer enormous opportunities for targeted intervention. The therapeutic potential …

… refueling the AML cell clones after front-line therapy. Based on these considerations, we
designed a study in which tyrosine kinase inhibitors were screened on the basis of their activity …

… Since aberrant tyrosine kinase activities are directly linked with poor … therapeutic targets
under development. Already, there is a range of clinically approved therapeutic tyrosine kinase …